News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McBarron Paul
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 70,200 options to buy
@ $0.5891, valued at
$41.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| McBarron Paul (See Remarks) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $4.32, valued at
$518.4k
|
|
| 12/09/2019 |
4
| McBarron Paul (E. VP, Fin, CFO and COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 13,022 options
@ $1.74, valued at
$22.7k
Granted 11,980 options
@ $1.56, valued at
$18.7k
|
|
| 01/07/2019 |
4
| McBarron Paul (E. VP, Fin, CFO and COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 270,079 options
@ $0.71, valued at
$191.8k
Granted 13,021 options
@ $1.74, valued at
$22.7k
Granted 11,980 options
@ $1.56, valued at
$18.7k
|
|
| 12/09/2015 |
4
| McBarron Paul (E.V.P., Fin, C.F.O. & C.O.O.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 260,432 options
@ $0.589, valued at
$153.4k
|
|
| 02/20/2015 |
4
| McBarron Paul (E.V.P.,Finance,C.F.O. & C.O.O.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 53,095 options
@ $0.86, valued at
$45.7k
|
|
| 12/10/2013 |
4
| McBarron Paul (E.V.P.,Finance,C.F.O. & C.O.O.) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 70,000 options
@ $4.61, valued at
$322.7k
|
|
| 05/22/2013 |
4
| McBarron Paul (EVP, Finance, CFO, COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Bought 8,333 shares
@ $3, valued at
$25k
Bought 4,615 shares
@ $3.0799, valued at
$14.2k
|
|
| 01/29/2013 |
4
| McBarron Paul (EVP, Finance, CFO, COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 6,712 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 12/08/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/26/2011 |
4
| McBarron Paul (EVP, Finance, CFO, COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $0.5, valued at
$6k
|
|
| 12/14/2010 |
4
| McBarron Paul (EVP, Finance, CFO, COO) has filed a Form 4 on Cyclacel Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options
@ $1.59, valued at
$119.3k
|
|
|
|